Among other anticancer strategies, SLeX-modified liposomes have been generated, which are able to inhibit adhesion of cancer cells by competition with ligands and can also be useful for anticancer drug delivering to cancer cells neighboring endothelial cells expressing E-selectin [282,283]. This evidence concerns the gene SELE and cancer.